SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Elon Musks warning that tighter debt markets could trigger failures and consolidation among AI neoclouds has fueled concern about Nebius and the broader sector. Traders are divided: bears see financing risks, while bulls argue Nebius is better positioned because it secured a large Citi credit facility and says it has funding to complete planned expansion.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Elon Musks warning that many neocloud providers could fail or consolidate has intensified scrutiny of CoreWeaves debt-heavy expansion and access to financing. Traders are split between fears of mounting credit pressure and bankruptcy risk and the view that strong AI demand and Nvidia ties could help CoreWeave weather a sector shakeout.

iShares Inc. - iShares MSCI Brazil ETF

iShares MSCI Brazil ETF

Brazils presidential runoff result, with Lula defeating the market-favored Bolsonaro, is driving discussion of a sharp EWZ selloff and heightened political and economic uncertainty. Traders debate whether the move is an overreaction and buying opportunity, while others point to downside hedging and further risk.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

A broad biotech-sector pullback, which traders attribute to rising-rate concerns, risk-off sentiment and rotation away from small-cap growth, is driving discussion around XBI. Some see support near its 200-day average and are buying the dip, while others warn the decline may continue; upcoming biotech data and M&A activity are viewed as potential supports but not confirmed catalysts.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

AXSMs steep selloff has focused attention on whether Auvelitys launch for Alzheimers-related agitation is gaining traction, with investors looking to the Q3 results for clearer prescription and sales evidence. Bulls argue that samples and long-term-care channels may be obscuring uptake, while skeptics point to lackluster visible prescription growth, high spending and managements silence as sources of uncertainty.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

Traders are focused on GEVs sharp selloff, widely attributed in the discussion to a bearish analyst rating and broader pressure on AI-infrastructure stocks amid financing and valuation concerns. Bulls argue the companys power-equipment demand and backlog remain strong, while bears point to weak price action and the risk of further declines.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFis steep selloff and test of 52-week lows are being debated amid inflation and rate-hike fears that could pressure lenders, alongside concerns about dilution and earnings quality. Bulls call the shares oversold and look to upcoming earnings for reassurance, while bears question whether growth will translate into stronger profits.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians upcoming quarterly results and forward guidance are the main focus, with traders debating whether delivery growth and the R2 ramp can translate into better margins and lower cash burn. The stocks slide to fresh lows has split sentiment between hopes for a rebound on strong results and concerns about continued losses, execution, and dilution.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARA is drawing attention after a steep selloff, with traders pointing to Bitcoin-linked volatility, weakness across miners and AI-infrastructure stocks, and concerns about debt, dilution, and the lack of signed AI/data-center tenants. Bearish posts see further downside and criticize management, while some investors argue the decline is overdone and expect an oversold rebound if Bitcoin firms or a lease deal emerges.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

Sharp swings in South Korean equitiesespecially chip-heavy Samsung and SK Hynixare driving discussion, with traders linking the pressure to concerns about AI-related stocks and debating whether KORUs steep drop is an oversold buying opportunity or a warning of further losses. The ETFs 3x daily leverage magnifies the volatility, while Goldman Sachs lower KOSPI outlook adds to the bearish case.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)PR NewswireSAN DIEGO, Oct. 20, 2026 SAN DIEGO, Oct. 20, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) (the...

Yakira Capital Management Calls on Atrium Therapeutics to Launch Strategic Review, Curb Cash Spending and Explain Dilutive Financing

Yakira Capital Management Calls on Atrium Therapeutics to Launch Strategic Review, Curb Cash Spending and Explain Dilutive Financing Yakira Capital Management Calls on Atrium Therapeutics to Launch Strategic Review, Curb Cash Spending and Explain Dilutive FinancingPR NewswireWESTPORT, Conn., Oct...

Atrium Therapeutics Announces $50 Million Private Placement

Atrium Therapeutics Announces $50 Million Private Placement Atrium Therapeutics Announces $50 Million Private PlacementPR NewswireSAN DIEGO, Oct. 8, 2026SAN DIEGO, Oct. 8, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) ("Atrium" or the "Company"), a biopharmaceutical company advancing...

Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)PR NewswireSAN DIEGO, Sept. 21, 2026 SAN DIEGO, Sept. 21, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) (the...

Atrium Therapeutics to Participate in Upcoming Investor Conferences

Atrium Therapeutics to Participate in Upcoming Investor Conferences Atrium Therapeutics to Participate in Upcoming Investor Conferences PR Newswire SAN DIEGO, Sept. 2, 2026 SAN DIEGO, Sept. 2, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA), abiopharmaceutical company advancing...

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, Aug. 20, 2026 SAN DIEGO, Aug. 20, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) (the...

Atrium Therapeutics Reports Second Quarter 2026 Financial Results

Atrium Therapeutics Reports Second Quarter 2026 Financial Results Atrium Therapeutics Reports Second Quarter 2026 Financial Results PR Newswire SAN DIEGO, Aug. 13, 2026 -- IND clearance for ATR 1072 and launch of Corventis Phase 1/2 trial in PRKAG2 syndrome ---- Achieved second milestone payment...

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration PR Newswire SAN DIEGO, Aug. 13, 2026 SAN DIEGO...

Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, July 20, 2026 SAN DIEGO, July 20, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) (the...

Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome

Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome PR Newswire SAN DIEGO, July 14, 2026...

Atrium Therapeutics, Inc. operates as a biopharmaceutical company that provides RNA therapeutics services to the heart to transform the standard of care for people living with cardiomyopathies. Its products pipeline includes two lead development candidates: ATR 1072 for PRKAG2 syndrome and ATR 1086 for PLN cardiomyopathy, both conditions are severe, life-threatening, rare autosomal dominant progressive cardiomyopathies with no approved treatment options and high unmet need. The company was founded on September 30, 2025 and is headquartered in San Diego, CA.

Atrium Therapeutics Inc.

Qualcomm, Tesla, Intellia Therapeutics, Avidity Biosciences, Dyne Therapeutics: Stocks Making The Biggest Moves Today

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Qualcomm shares were up more than 11% in Monday’s midday session after the company unveiled two AI accelerator chips.</li><li>Intellia Therapeutics declined by more than 44% after the company announced a temporary pause in patient dosing and screening for two of its late-stage trials.</li><li>Avidity Biosciences shares were up nearly 42% in Monday’s midday trade after Novartis AG (NVS) agreed to acquire the former for $12 billion.</li></ul>U.S. equities surged in Monday’s midday trade after trade tensions with China cooled down after officials of the two countries met over the weekend.President Donald Trump expressed optimism about striking a deal with China. “I've got a lot of respect for President Xi, and I think we're going to come away with a deal. We have China coming and its going to be very interesting,” he told reporters aboard Air Force One, according to a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/world/asia-pacific/trump-says-he-might-sign-final-tiktok-deal-thursday-2025-10-27/">report</a> by Reuters.President Trump is scheduled to meet his Chinese counterpart, President Xi Jinping, on Thursday.The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which mirrors the S&amp;P 500 index, was up 0.94% at the time of writing, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ), which mirrors the Nasdaq 100 index, rose 1.56%. The&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA), which tracks the Dow Jones Industrial Average, gained 0.42%.<h2 class="st-heading-2">Here are the top stocks making the biggest moves in Monday’s midday trade:</h2><a href="https://stocktwits.com/symbol/QCOM">Qualcomm Inc. (QCOM)</a>Qualcomm shares were up more than 11% in Monday’s midday session after the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/qcom-stock-jumps-after-company-launches-ai-chips-to-take-on-amd-nvidia/cLG0OGnR3M6">unveiled</a> two artificial intelligence (AI) accelerator chips, the AI200 and AI250, aimed at enterprise and cloud customers.<a href="https://stocktwits.com/symbol/QCOM">QCOM stock</a> is up 22% year-to-date.<a href="https://stocktwits.com/symbol/TSLA">Tesla Inc. (TSLA)</a>Tesla shares gained nearly 6% in Monday’s midday trade. Cantor Fitzgerald hiked its price target on the stock to $510 from $355, while maintaining an ‘Overweight’ rating, according to TheFly. The firm cited better-than-expected third-quarter (Q3) revenue, gross margin, and free cash flow.<a href="https://stocktwits.com/symbol/TSLA">TSLA stock</a> is up 14% year to date.<a href="https://stocktwits.com/symbol/NTLA">Intellia Therapeutics Inc. (NTLA)</a>Intellia Therapeutics declined over 44% in Monday’s midday session after the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-ntla-stock-slump-pre-market-today/cLG07OdR3Ms">announced</a> a temporary pause in patient dosing and screening for two of its late-stage trials for Nex-z after a patient was hospitalized.<a href="https://stocktwits.com/symbol/NTLA">NTLA stock</a> is up 24% year to date.<a href="https://stocktwits.com/symbol/RNA">Avidity Biosciences Inc. (RNA)</a>Avidity Biosciences shares were up nearly 42% in Monday’s midday trade after Novartis AG (NVS) agreed to acquire the former for $12 billion. The deal offers Avidity investors $72 per share, a 46% premium over the stock’s Friday closing price.<a href="https://stocktwits.com/symbol/RNA">RNA stock</a> is up 141% year to date.<a href="https://stocktwits.com/symbol/DYN">Dyne Therapeutics Inc. (DYN)</a>Dyne Therapeutics shares were up 41% in Monday’s midday session following the acquisition of Avidity by Novartis. Analysts at Morgan Stanley&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dyne-therapeutics-stock-soars-after-rival-avidity-biosciences-gets-acquired-by-novartis/cLG0X2XR3u7">stated</a> that the Avidity acquisition provides positive read-through to Dyne, as reported by TheFly. Both Avidity and Dyne are advancing therapies for rare muscle diseases, myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystrophy.<a href="https://stocktwits.com/symbol/DYN">DYN stock</a> is up 3% year to date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/apple-stock-hits-all-time-high-market-capitalization-inches-toward-4-trillion/cLG0gUVR3u9">Apple Stock Hits All-Time High, Market Capitalization Inches Toward $4 Trillion</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A bull statue and a bear statue stand outside the Frankfurt Stock Exchange on April 7, 2025 in Frankfurt, Germany

Qualcomm shares were up more than 11% in Monday’s midday session after the company unveiled two AI accelerator chips.

Intellia Therapeutics Inc

Qualcomm, Inc.

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$8.20
Prev Close	$8.16
Open	$8.06
Dividend Yield	N/A
50-Day Moving Average	$10.26
Beta	0.74
Avg. Volume	418,728.24
PE Ratio	N/A

52-Week High	$16.77
52-Week Low	$7.49
Market Capitalization	$182.66M
EPS (Annual)	-$2.89
Price to Book	0.65
Revenue Per Employee	N/A

Feed

News

Sentiment

Earnings

Fundamentals

Info

RNA Fundamentals